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ABBREVIATIONS 
 
 
CI Confidence intervals 
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HUF Hungarian forint 
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PROM Premature rupture of membranes 
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1. INTRODUCTION 
According to the World Health Organization, the global number of deaths in the first 
year of life was 4.6 million, in 2013 [1]. The global infant mortality rate was 31.7 per 
1,000 live births in 2013 [1]. About five times higher infant mortality was observed in 
Africa (60 per 1,000 live births) than in Europe (11 per 1,000 live births) [2]. 
Furthermore, 75% of infant deaths that occurred before one year of age were infants 
who were born prematurely [3]. 
Preterm birth (based on less than 37 completed weeks of gestation) is one of the most 
significant problems in perinatology. Beck et al [2] reported that the World Health 
Organization estimated that 9.6% births worldwide were preterm in 2005 which 
translated into about 12,9 million births definable as preterm [4]. Furthermore, about 0.5 
million (6.2%) and 8,198 (8.4%) births were preterm in Europe and Hungary in 2005, 
respectively [4-5].  
Various infections including Chlamydia trachomatis could cause preterm birth [6-7]. In 
pregnancy, Chlamydia trachomatis (C. trachomatis) may cause a wide range of serious 
complications, which include premature delivery, post-partum endometritis, ophthalmia 
neonatorum and neonatal pneumonia [8]. Furthermore, C. trachomatis is a major cause 
of neonatal morbidity and mortality [9-10]. Chlamydial infections of the genital tract are 
a problem worldwide. Despite the fact that chlamydial infection is relatively rare, the 
rate of genital chlamydial infection has increased in Hungary, since 2006 [11]. 
In this thesis, we present two epidemiological studies investigating i) the infant 
mortality in Hungary and ii) the role of maternal Chlamydia trachomatis in preterm 
birth.  
 
1.1. Trends in infant mortality rates in Hungary between 1963 and 2012  
(Study I) 
 
Since 1981, the numbers of live births has been lower than the number of deaths in 
Hungary. A consequence of this trend is that the population fell below 10 million in 
Hungary in 2011 [5].  
Infant mortality has been investigated in several countries and certain risk factors, 
including socio-economic, geographic and environmental, have been implicated [12-
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13]. Infant mortality rates have decreased in developed countries over the last two 
decades [14], including Hungary. Wang et al [1] reviewed the global infant mortality 
rate and reported an infant mortality of 4.6 per 1,000 live births in Hungary in 2013. 
Nevertheless, Hungary had the 2nd highest rate of infant mortality out of 24 European 
countries in the 2011 and 2012 tables produced by the Organization for Economic Co-
operation and Development [4]. Figure 1 depicts the published European infant 
mortality rates per 1,000 live births in 2012. Only the mortality rate of 7.8 per 1,000 live 
births in Slovakia was higher than in Hungary.  
 
Figure 1. European infant mortality rates in 2013 [4]. 
 
However, in a recent paper, the Hungarian infant mortality rate of 4.6 per 1,000 live 
births in 2013 was slightly lower than the Central European average of 5.6 per 1,000 
live births per year, but was higher than the reported Western European average of 3.2 
per 1,000 live births [1]. In spite of these annual reported trends in Hungarian infant 
mortality, rates have not yet been investigated in any detail.  
 
 
1.2. Chlamydia trachomatis infection and the risk of perinatal mortality in 
Hungary (Study II) 
 
Halberstaedter and von Prowazek described the transmission of trachoma from humans 
to orangutans by experimental infection in Java in 1907 [15]. These newly discovered 
organisms were called Chlamydozoa. Similar inclusions were described subsequently in 
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the conjunctival cells of babies with non-gonococcal ophthalmia neonatorum in cervical 
epithelium from some of their mothers and in urethral epithelium from male patients 
with non-gonococcal urethritis [16]. 
C. trachomatis infection is an STD that is common worldwide and have surpassed 
gonorrhoea as the number one in the United States (USA), the United Kingdom and the 
Scandinavian countries [17]. Sweden was the first country in the world to establish a 
national laboratory service for detecting chlamydial infections. In the Netherlands in 
1987, about 90 000 individuals were estimated to be infected with C. trachomatis [18]. 
The annual cost of chlamydial infection and its sequelae was estimated at $2.2 billion in 
1990 in USA [19]. 
 
Babies born vaginally to mothers with cervical chlamydial infection are at risk of 
becoming colonized or infected with an organism. Estimates of the risk are as high as 
50% [7,18-19] 
 
Epidemiological evidence indicates that chlamydial infections of the genital tract are a 
global problem. Premature delivery is the most important perinatal problem in Hungary 
as Czeizel [20] and Orvos [21] have reported. In most cases the underlying cause is not 
known. A breakthrough in the prevention of preterm birth requires more data about the 
causes leading to premature uterine contractions.  
The nationwide registration of C. trachomatis in Hungary has been performed since 
1995 in ten clinical, hospital and public health laboratories. Chlamydia diagnostic 
methods have been carried out since 1985 in some research centres and hospital 
laboratories. The rate of C. trachomatis cases in the past decades are shown in Figure 2 
[11]. 
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Figure 2. The rate of the detected genital chlamydial infection between 1986 and 2013 
in Hungary [11] 
 
A large number of anecdotal observations suggest that C. trachomatis infections may 
have a causative role in the origin of premature delivery [7, 22-23]. Consequently, a 
multicentre survey was carried out in order to determine the prevalence and risk factors 
for C. trachomatis infection in the pregnant population in Hungary [24-25]. The data set 
from the Hungarian survey was reanalysed in order to provide further information on 
the relationship between neonatal mortality and genital chlamydial infections and to 
estimate the frequency of these infections.  
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2. AIMS OF THE THESIS 
 
2.1. Trends in infant mortality rates in Hungary between 1963 and 2012  
(Study I) 
 
 In the longitudinal study, changes in infant mortality rates, annual trends and the 
effect of some possible risk factors related to deaths under the age of one year 
were investigated during the 50-year interval between 1 January 1963 and 31 
December 2012, in Hungary.  
 Furthermore, seasonality analyses of cyclic trends in infant mortality rates, were 
also carried out. 
 
2.2. Chlamydia trachomatis infection and the risk of perinatal mortality in 
Hungary (Study II) 
 
 In parallel with a study [24-25] to characterize the role of C. trachomatis in 
preterm birth, a multicenter survey was carried out in order to determine the 
prevalence and risk factors of C. trachomatis infection in the population of 
asymptomatic women.  
 A cost-effectiveness analysis of chlamydial infection screening and its sequelae 
was carried out, to aid in developing screening criteria for genital chlamydial 
infection in women, in Hungary. 
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3. MATERIALS AND METHODS 
 
3.1. Trends in infant mortality rates in Hungary between 1963 and 2012  
(Study I) 
 
3.1.1. Investigation of annual trends and risk factors 
 
Infant death was defined as death after live birth and before the age of one year. Data on 
the numbers of live births and infant deaths were obtained from the published 
nationwide population register of the Hungarian Central Statistical Office [5]. The 50-
year period between 1963 and 2012 was considered in this analysis. Annual birth and 
infant death data were available, with birth weight, sex, maternal age and maternal 
education, for both live births and infant death cases throughout the full 50-year period. 
Complete information was available for birth weight and sex. Maternal age was missing 
for 261 (0.19%) of the records and maternal education was missing for 364 (0.27%). 
Maternal age was also categorised using younger or older than 35-years-of-age. 
Maternal education was categorised as no primary school attended, primary school 
attended, vocational or secondary grammar school attended and higher education, which 
was regarded as the default group in the risk analyses. A birth weight of less than 2,500 
g was regarded as a low birth weight. 
  
The data concerning the cause of infant deaths were published annually by the Central 
Statistical Office. These data were classified according to the ICD10 codes. The main 
categories were: congenital malformation and certain conditions originating in the 
perinatal period, infectious and parasitic diseases, diseases of the nervous system and 
sense organs, diseases of the respiratory system, diseases of the digestive system and 
other cause of infant death, for example neoplasms, diseases of the circulatory system. 
The unknown or missing causes of deaths were officially classified into other causes of 
deaths [5].  
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3.1.2. Investigation of seasonal trends  
The age of the infant death was categorised for neonatal (zero to 27 days) and post-
neonatal (28-364 days) mortality according to World Health Organization 
recommendations. The numbers of infant deaths were available at zero, one to six, 
seven to 13 and 14-27 days and at one to two, three to five and six to 11 months. Hence, 
the numbers of death in the early neonatal period (zero to six days) were calculated by 
adding the numbers of deaths that occurred within 24 hours and during one to six days 
after birth. Furthermore, the numbers of both monthly live birth and infant deaths, 
including the date of death, were available. However, monthly data on the cause of 
infant deaths were not available. 
  
3.1.3. Statistical methods 
Because the observed variance was greater than the mean of the death and birth 
variables, this is known as over-dispersion. Therefore the negative binomial regression 
method with the Huber–White estimator was applied to investigate the trends across 
annual rates and investigate the effect of possible risk factors - low birth weight, 
maternal education and sex – in relation to infant mortality [26]. Relative risks (RR) and 
95% confidence intervals (95% CIs) were calculated. Trends in the annual number of 
infant deaths by cause of death were also investigated. 
 
Data on the month of the death were aggregated over the study period. Cyclic trends in 
these monthly data were investigated using the Walter-Elwood method [27] and the 
logistic regression method using both sine and cosine functions [28]. This statistical test 
was used to retain the information on the connection of time periods by describing the 
seasonal pattern as one sine and one cosine function. These functions can be 
incorporated in a regression model that allows the investigation of single or double 
peaks of seasonality. Monthly cyclic trends (seasonality) were investigated in babies 
who died in the early neonatal period of zero to six days, by looking at babies who died 
within 24 hours after birth and babies who died during the first week after birth.  
 
P-values of less than 0.05 were considered to be statistically significant. The Type I 
error was reduced using Bonferroni corrections. P-values were multiplied by the total 
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number of significance tests. All analyses were performed using STATA Software 
version 9.0 (Stata Corp LP, College Station, Texas, USA) 
 
 
3.2. Chlamydia trachomatis infection and the risk of perinatal mortality in 
Hungary (Study II) 
3.2.1. Study population 
The cross-sectional study started and terminated in 1995 in five different centers in 
three regions of Hungary: Western Hungary (Szombathely); Middle Hungary (Budapest 
and Szeged); Eastern Hungary (Miskolc and Nyíregyháza). The non-amplified nucleic 
acid hybridization method (PACE 2 Gen-Probe) was applied for the examination of C. 
trachomatis. Today, the sensitivity and specificity of this method are only 70% and 99% 
[29], respectively, and Bayes’ theorem was therefore applied to assess the prevalence of 
the infection [30].  
 
 
3.2.2. Data collection 
The envisaged sample size was calculated by using Hsieh’s formula [31]. The target 
population was women of reproductive age who were registered with a hospital, all of 
whom were asymptomatic as concerns genital infection. The sample was selected by 
using simple random sampling. 
An interviewer-administered standardized questionnaire was completed, in which age, 
social and marital status and previous obstetrical history data were recorded. Data 
management was carried out with self-developed software. 
 
3.2.3. Statistical analysis 
Statistical analyses were performed with SPSSS for Windows (8.0 version) software 
packages. Independent predictors of chlamydial infection were assessed by using 
multiple logistic regression analysis. Odds ratios, as estimators of relative risks, together 
with their corresponding 95% confidence intervals (CI), were computed. A p value of 
less than 0.05 was taken to indicate a significant effect.  
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3.2.4. The cost-effectiveness analysis 
An incremental cost-effectiveness analysis was performed to compare the strategies of 
screening with the ELISA method (the sensitivity and specificity of this test are 70% 
and 99%, respectively [29]) for the detection of C. trachomatis (strategy A), screening 
with use of the amplified Gen-Probe method (the sensitivity and specificity of this test 
are 92% and 99%, respectively) [29] for the detection of C. trachomatis (strategy B), 
and no application of screening methods (strategy C). Costs were based on local charges 
of the Hungarian Health Insurance [32]. 
4. RESULTS 
4.1. Trends in infant mortality rates in Hungary between 1963 and 2012 
 (Study I) 
 
During the 50-year interval, there were 6,336,976 live births (3,247,936 boys and 
3,089,040 girls) and 136,537 infant deaths (77,751 boys and 58,786 girls) in Hungary. 
There were 47,055 (34.5%) within the first 24 hours of delivery, 87,757 (64.3%) during 
the early neonatal period and 17,134 (12.5%) during the late neonatal period. Thus 
104,891 (76%) of the infant deaths occurred during the first 28 days after birth. The 
number of normal and low birth weight infant deaths were 43,578 (32%) and 92,959 
(68%), respectively. 
 
Figure 3. Infant mortality rate in Hungary between 1963 and 2012 
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The annual infant mortality rate declined by 88.6% from the maximum of 42.9 per 
1,000 births in 1963 to the minimum of 4.9 per 1,000 births in 2012 (Figure 3). There 
was a significant RR trend per annum of 0.954 (95% CI 0.953–0.955; p<0.001). A 
similar decreasing trend was detected for the annual rate of early neonatal deaths with 
an annual RR of 0.944 (95% CI 0.941–0.948; p<0.001). 
 
A significantly increased risk of infant mortality was found in boys, with an RR of 1.23 
(95% CI 1.19-1.28, p<0.001), than girls. A significantly increased risk of infant death 
with an RR of 1.73 (95% CI: 1.64 , 1.83; p<0.001) was found in mothers over the age of 
35 compared to mothers under this age.  
 
The proportion of mothers in the no primary school completed group decreased from 
32.3% to 7.2% during the 50-year period. However, the proportion of mothers in the 
only primary school completed group decreased by only 24% from 56.8% to 32.8% in 
the last 20 years of the study. The 10-year interval aggregated numbers of infant deaths 
in the different maternal education groups are summarised in Table 1. The proportion of 
infant deaths was 5.7% in the group of mothers with longer education. In contrast, the 
overall proportion of mothers in the only primary school and no school groups were 
52.2% and 20.6%, respectively. Thus, the risk of an infant’s death was higher in 
mothers with lower levels of education than those with higher levels of education 
(RR=1.31, 95% CI 1.30-1.32, P<0.001). For those whose mothers only completed 
secondary grammar or vocational school the RR was 1.28 (95% CI 1.25–1.31). For 
those whose mothers only completed primary school the RR was 1.72 (95% CI 1.67–
1.75). For those whose mothers did not complete primary school the RR was 2.23 ( 95% 
CI 2.17–2.29). However, the highest risk of infant mortality with an RR of 20.2 (95% 
CI 19.9–20.4 p<0.001) was observed in the low birth weight group compared with the 
normal birth weight group. Nevertheless, similar significantly declining (p<0.001) 
annual trends in infant mortality rates by sex, birth weight, maternal education and 
maternal were found in all subgroups as well as overall. 
 
 
 
 
 
Table 1. The numbers of infant deaths and maternal education in Hungary between 1963 and 2012. Mortality rates per 1,000 live births are given 
by time period and level of education. 
School 
attended 
Primary school  
0–7 grades 
 
Completed 
primary school  
8 grades 
 
Completed 
secondary school 
or vocational 
school 
 
Completed third-
level school 
 Total 
period 
No. of 
deaths 
mortality 
rates 
No. of 
deaths 
mortality 
rates 
No. of 
deaths 
mortality 
rates 
No. of 
deaths 
mortality 
rates 
No. of 
deaths 
mortality 
rates 
1963-1972 17,390 243.83 27,053 98.7 7,893 10.54 1,478 4.25 53,814 37.31 
1973-1982 6,854 48.8 25,478 55.21 10,247 11.29 2,690 18.76 45,269 27.38 
1983-1992 2,317 13.77 12,325 31.91 5,243 8.23 1,827 27.28 21,712 17.25 
1993-2002 1,129 7.72 4,478 9.21 3,607 10.34 861 17.37 10,075 9.77 
2003-2012 381 1.44 1,739 3.68 2,309 13.03 874 31.77 5,303 5.63 
1963-2012 28,071 35.48 71,073 34.15 29,299 10.39 7,730 12.17 136,173 21.52 
 
 
  
 
 
 
 
Table 2. Annual number of infant deaths by cause of death in Hungary between 1963 and 2012 (N=136,537) 
Cause of 
deaths 
Congenital 
malformation and 
certain conditions 
originating in the 
perinatal period 
Infectious and 
parasitic 
diseases 
Diseases of the 
nervous system 
and sense organs 
Diseases of the 
respiratory 
system 
Diseases of the 
digestive 
system 
Other diseases  Total 
ICD10 
codes  
Q00–Q99;  
P00–P96 
A00–B99 G00–G99 J00–J99 K00–K93    
Trends* 0.956 
(0.954-0.958) 
0.960 
(0.953-0.967) 
0.946 
(0.942-0.950) 
0.918 
(0.912-0.925) 
0.899 
(0.891-0.907) 
  0.954 
(0.953-0.955) 
Period         
1963-1972 41,673 (38.1%)  521 (43.0%) 1,986 (41.9%) 5,836 (50.2%) 2,431 (62.3%) 1,367 (24.6%)  53,814 (39.4%) 
1973-1982 36,869 (33.7%)  276 (22.8%) 1,563 (33.0%) 3,724 (32.0%) 1,214 (31.1%) 1,628 (29.3%)  45,274 (33.2%) 
1983-1992 17,888 (16.3%)  233 (19.2%)  746 (15.7%) 1,466 (12.6%)  164 (4.2%) 1,230 (22.2%)  21,727 (15.9%) 
1993-2002 8,431 (7.7%)  139 (11.5%) 299 (6.3%) 486 (4.2%)  64 (1.6%)  830 (15.0%)  10,249  (7.5%) 
2003-2012 4,646 (4.2%)  43 (3.5%) 146 (3.1%) 117 (1.0%)  27 (0.7%) 494 (8.9%)  5,473 (4.0%) 
1963-2012 109,507 (100%) 1,212 (100%) 4,740 (100%) 11,629 (100%) 3,900 (100%) 5,549 (100%)  136,537 (100%) 
*Relative risk(RR) and 95% confidence interval (95% CI) 
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Table 2 shows numbers of infant deaths together with the cause of death Similarly, the 
trends were significantly (p<0.001) decreased in annual infant mortality during the 
study period in the all cause of death categories as well as in all infant mortality during 
the study period (Table 2). 
 
The monthly cyclic trends of mortality were investigated among all infants and, 
separately, in the groups of cases who died during the early neonatal period, within 24 
hours after birth and during the first week after birth. The monthly numbers of babies 
who died within 24 hours of birth, infant deaths and early neonatal deaths used in the 
seasonal analyses are given in Table 3.  
 
Table 3. The monthly numbers of babies who died within 24 hours of birth, infant 
deaths and early neonatal deaths used in seasonal analyses. 
Months Numbers of babies 
who died within 24 
hours of birth† 
Numbers of early 
neonatal deaths† 
Numbers of all 
infant deaths† 
Numbers of 
live births* 
January 4,189 7,682 12,300 532,829 
February 3,659 6,858 11,010 497,184 
March 4,229 7,793 12,279 549,937 
April 4,363 8,010 12,236 522,361 
May 4,345 8,101 12,325 544,044 
June 3,919 7,369 11,242 534,077 
July 3,922 7,345 11,123 569,752 
August 3,634 7,017 10,763 551,010 
September 3,515 6,579 10,146 537,334 
October 3,834 6,959 10,821 513,773 
November 3,633 6,840 10,699 483,878 
December 3,813 7,204 11,593 508,293 
Total 47,055 87,757 136,537 6,344,472* 
*The monthly numbers of births included stillbirths between 1963-1968 (6). 
†The numbers based on date at death 
 
 
 
19 
 
A significant cyclic trend in all infant mortality was revealed by the logistic regression 
model, with a peak of deaths during late February (p<0.001). Similarly, a significant 
cyclic trend was found with a peak of deaths during March both in the group of cases 
who died within 24 hours after birth (p<0.001) and in the group of cases who died 
during the early neonatal period (p<0.001), respectively.  
In a sensitivity analysis, the Walter–Elwood method was applied to investigate the 
cyclic trends and this provided similar peaks to the logistic regression method. The 
peaks were in February for all infant deaths (p<0.001) and in March in both the group of 
cases who died within 24 hours after birth (p<0.001) and in the group of cases who died 
during the early neonatal period (p<0.001). Seasonality models with double peaks were 
also investigated using the logistic regression method. In double peak models neither 
the sine nor cosine variables were significant for all infants. However a significant 
(p=0.045) double peak in May and November was detected in the group of cases who 
died during the early neonatal period. The cyclic trends are depicted in Figure 4. 
 
 
 
Figure 4. Seasonal variation in month of infant deaths 
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4.2. Chlamydia trachomatis infection and the risk of perinatal mortality in 
Hungary (Study II) 
4.2.1. Characteristics of study subjects 
 
Accordingly, a total of 1300 pregnant women were examined for the occurrence of C. 
trachomatis. The overall average C. trachomatis infection rate was found to be 4.5%, 
the data varying in the range 1.5-6.8% between the regions (Table 4). 
 
Table 4. Risk factors for C. trachomatis infections among 1300 pregnant women. Odds 
ratios and p values from multivariate logistic regression analysis. An odds ratio of 1.0 
indicates the reference category. 
 No. 
of 
cases 
C. trachomatis- 
positive 
Rate of 
infection 
(%) 
Odds ratio  
(95% CI) 
Probability 
level of 
significance 
Regions     p=0.002 
Eastern Hungary 
Middle Hungary 
Western Hungary 
354 
484 
426 
24 
28 
7 
6.8 
5.8 
1.5 
3.5(1.5-8.3) 
4.6(1.9-11.1) 
1.0 
 
Age range(years)     p=0.014 
15-19 
20-24 
25-28 
29-32 
33-38 
39 
87 
410 
439 
206 
119 
39 
11 
25 
17 
2 
3 
1 
12.6 
6.1 
3.9 
1.0 
2.5 
2.6 
6.7(0.6-39.8) 
2.7(0.4-21.2) 
1.8(0.2-14.3) 
0.4(0.1-4.4) 
0.9(0.1-9.1) 
1.0 
 
Marital status     p=0.0436 
Single 
Divorced 
Married 
38 
168 
1094 
5 
15 
39 
13.2 
8.9 
3.6 
3.3(1.1-9.6) 
1.7(0.9-3.5) 
1.0 
 
 
The difference between the average ages of the C. trachomatis-infected patients (23.8 
(SD 5.7) years) and the non-infected women (27.1 (SD 5.8) years) was statistically 
significant (p<0.001). Certain potential risk factors relating to the infection were 
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examined. As shown in Table 1, a young age, an unmarried status (single or divorced) 
and the regional difference (there was only a 1.5% rate of chlamydial infection in 
Western Hungary where the rate of unemployment has been lowest in the past few 
years) proved to be statistically significant predictors of the infection.  
 
Furthermore, the group aged under 20 years displayed a very high rate of infection 
(12.6%). However, with Bayes' theorem the overall estimated prevalence of chlamydial 
infection was 5.1%, the assessed infection rates for the age groups varying in the range 
0.6-16.9% (Table 5.). 
 
Table 5. Observed and estimated C. trachomatis infection rates for the age groups. 
Age  
range 
(years) 
No. 
of 
cases 
C. trachomatis- 
positive 
Observed rate of 
infection (%) 
Estimated rate of 
infection (%) 
15-19 
20-24 
25-28 
29-32 
33-38 
39 
87 
410 
439 
206 
119 
39 
11 
25 
17 
2 
3 
1 
12.6 
6.1 
3.9 
1.0 
2.5 
2.6 
16.9 
7.5 
4.2 
0.6 
2.3 
2.4 
Total 1300 59 4.5 5.1 
 
 
4.2.2. Decision analysis 
Decision analysis (Figure 5) was used to assess the potential outcome of chlamydial 
infection, and was modeled on an MS-Excel spreadsheet.  
The major high-cost complications of chlamydial infection are pelvic inflammatory 
disease (PID), ectopic pregnancy, and tubal infertility. Women with untreated 
chlamydial infection were assumed to have a 20% risk of PID, with 10% of these cases 
necessitating hospitalization [33]. Ten percent of the women in whom PID developed 
were assumed to experience a subsequent ectopic pregnancy [34]. Tubal infertility was 
estimated in 20% of the women with PID [35]. Each infected woman was assumed to 
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have one infected partner. Approximately 40% of men were assumed to have urethritis, 
8% of whom required hospitalization because of epididymitis [36].  
 
 
Figure 5. Decision tree for cost-effectiveness analysis of three screening strategy for 
female genital chlamydial infection. 
 
 
The main complications in infants born to mothers infected with Chlamydia are 
conjunctivitis and neonatal pneumonia [37-40]. An earlier study of pregnant women, 
revealed that 17.1% of C. trachomatis-positive newborns were treated in neonatal 
intensive care units (NICU), and congenital pneumonia was identified in 7.1% of the 
newborns of Chlamydia-infected women [25,40].  
Furthermore, a significant difference (p=0.001) was between the rate of premature 
uterine activity that occurred in the infected group (8.1%), and the non-infected group 
(5.3%). The overall perinatal mortality rate was 2.0% and a significantly higher 
(p=0.042) mortality rate was detected in the group of C. trachomatis-positive patients 
than in the group of negative patients. In the group of perinatal death cases, the maternal 
C. trachomatis infection rate was 10.1%.[41]  
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Table 6. Conditional probabilities and costs used in cost-effectiveness analysis of  
C. trachomatis screening 
 Probability 
(%) 
(ELISA) 
Cost/ 
case($) 
ELISA 
Condition Probability 
(amp. Gen) 
Cost/case 
($) 
(amp. Gen) 
Screening and 
treatment 
     
C. trachomatis 
prevalence 
12.6 7  12.6 13.9 
Sensitivity of test 70   92  
Specificity of test 99   99  
Effectiveness of the 
treatment 
95  All infected and 
treated 
95  
Complications of 
treatment 
7 8 All treated 7 8 
Sequalae of untreated  
infection in women 
     
PID rate 20  Untreated 
chlamydial infection 
20  
PID outpatient treatment 100 56 Symptomatic PID 100 77 
PID inpatient treatment 20 166 All PID 20 166 
Ectopic pregnancy 10 357 All PID 10 357 
Tubal infertility 20 86 All PID 20 86 
In vitro fertilization 20 2,833 All PID 20 2,833 
Disease in male sex 
partners 
     
Transmission rate 33   33  
Urethritis, epididymytis 
(outpatient) 
40 15 Male with 
chlamydia 
40 22 
Epididymytis (inpatient) 8 227 Symptomatic 
urethritis 
8 227 
Neonatal diseases      
Birth rate 5   5  
Neonatal pneumonia 7 1,024 Maternal chlamydial 
infection 
7 1,024 
Preterm birth and 
treatment in NICU 
10 707 Maternal chlamydial 
infection 
10 707 
Treatment  22   29 
Partner treatment  22   29 
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Table 7. Number of cases of the three strategies (CT: C. trachomatis; NICU: neonatal 
intensive care unit) 
 No 
screening 
Screening 
using 
ELISA 
Prevented 
cases 
Screening 
using amp. 
Gen-Probe 
Prevented 
cases 
Total women 400,000 400,000  400,000  
Women tested 0 400,000  400,000  
Women with CT 50,400 50,400  50,400  
Women without CT 349,600 349,600  349,600  
True-positive  35,280  46,368  
False-positive  3,496  3,496  
True-negative  346,104  346,104  
False-negative  15,120  4,032  
Couple treated  38,776  49,864  
Treatment complications  2,714  3,490  
Women with CT (after) 50,400 16,355 34,045 5,655 44,745 
Women with PID 10,080 3,271 6,809 1,131 8,949 
Outpatient treatment of 
PID 
10,080 3,271 6,809 1,131 8,949 
Inpatient treatment of 
PID 
2,016 654 1,362 226 1,790 
PID surgery 2,016 654 1,362 226 1,790 
Infected male 16,632 5,397 11,235 1,866 14,766 
Urethritis, epididymytis 
outpatient 
6,653 2,159 4,494 746 5,906 
Epididymytis, inpatient 333 108 225 37 295 
Ectopic pregnancy 1,008 327 681 113 895 
Tubal infertility 2,016 654 1,362 226 1,790 
Births to women with CT 2,520 818 1,702 283 2,237 
Neonatal pneumonia 176 57 119 20 157 
Preterm birth and 
treatment in NICU 
252 82 170 28 224 
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The prevalence of C. trachomatis infection used in the analysis was 12.6%. The costs of 
screening included the costs of tests, the therapy if tests were positive, the side-effects 
of therapy and empirical therapy of one male partner (Table 6). The cost of the 
diagnostic tests was $7 and $13.9 per test for the ELISA and Gen Probe methods, 
respectively. The cost of treating a woman twice a daily with doxycycline for 14 days 
was $22 and $29 for the ELISA and Gen-Probe methods (including a control test), 
respectively. We assumed that 3.5% of both women and men would have severe nausea 
and vomiting from doxycycline and would not be cured [42]. The birth rate was 
estimated as 5% per year. Table 7 displays the conditional probabilities and costs used 
in the cost-effectiveness analysis. Costs were based on local charges and were measured 
in US dollars (the exchange rate at that time was 1 USD=243.4 Hungarian forints). The 
analysis included only direct costs.  
Sensitivity analysis was performed for outcomes in the model in order to determine how 
changes in estimated values affected the results and to identify “break-even” prevalence 
points
 
[43]. 
Age-stratified demographical data on the female Hungarian population were available 
from the Hungarian National Statistical Office
 
[5]. Approximately 400,000 women 
belonged in the group aged between 15 and 19 years on January 1, 1996. 
 
4.2.3. Cost-effectiveness analysis 
 
The most cost-effective strategy was strategy A (screening for C. trachomatis by using 
the ELISA method) (Table 8). Strategy B (screening for C. trachomatis by using Gen-
Probe method) was slightly less cost-effective than neither testing nor treating (strategy 
C). Strategy A would eradicate a total of 34,045 chlamydial infections in 400,000 
women with a chlamydial prevalence of 12.6%. 
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Table 8. Costs of each decision option 
 None ELISA GEN 
Testing  2,773,666.7 5,547,333.3 
Treatment for positive test  1,717,582.9 2,900,173.3 
Complications  22,619.3 29,087.3 
PID outpatient treatment 565,517.4 183,510.4 86,978.2 
PID inpatient treatment 334,098.2 108,414.9 37,485.8 
PID surgery 172,994.6 56,136.8 19,410.0 
Urethritis, epididymytis outpatient 101,945.8 33,081.4 16,614.9 
Epididymytis, inpatient 75,395.2 24,465.7 8,459.3 
Ectopic pregnancy 359,953.4 116,804.9 40,386.8 
Tubal infertility 5,712,000.0 1,853,544.0 640,886.4 
Neonatal pneumonia 180,679.5 58,630.5 20,272.2 
Preterm birth and treatment in NICU 178,086.5 57,789.1 19,981.3 
Total 7,680,670.8 7,006,246.6 9,367,069.0 
 
The results of the incremental cost-effectiveness analysis are shown in Table 9. Strategy 
A was more cost-effective than no screening, saving $20 per case prevented. As 
compared with no screening, strategy B involved an extra cost of approximately $221 
for each case prevented, but prevented an additional 10,000 more cases relative to 
strategy A.  
 
Table 9. Incremental cost-effectiveness of three screening strategies for C. trachomatis 
infection 
Screening strategy Total cost ($) Cases of  
C. trachomatis 
not detected 
Cases of  
C. trachomatis 
prevented 
Cost-effectiveness 
ratio  
($) 
No screening 7,680,670.8 50,400   
ELISA 7,006,246.6 16,355 34,045 (20) 
Gen-Probe 9,367,069.0 5,655 44,745 221 
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4.2.4. Sensitivity analysis 
With each assumption varied over a range of possible values, sensitivity analysis was 
performed. The policy of strategy B was less cost-effective than neither testing nor 
treating, unless certain conditions were satisfied. Table 10 displays the results of the 
sensitivity analysis. If the costs of the diagnostic test were less than or equal to $10.3, or 
if the prevalence of infection in women were greater than 16.7%, screening strategy B 
would be more cost-effective than neither testing nor treating. Additionally, if the 
conditional probability of tubal infertility exceeded the 25% used in the cost-
effectiveness analysis, screening method B would be cost-effective. 
 
Table 10. One-way sensitivity analysis: breakpoints at which testing with the amplified 
Gen-Probe method for screening become more cost-effective than no testing. 
 Amplified 
Gen probe 
Cost of test <$10.3 
Infection prevalence >16.7% 
PID rate >24% 
Probability of tubal infertility in an untreated woman >25% 
 
  
 
 
28 
 
5. DISCUSSION 
 
5.1. Trends in infant mortality rates in Hungary between 1963 and 2012  
(Study I) 
 
5.1.1. Strengths and weaknesses of the study 
Our population data were obtained from published tables. However a long study period 
of 50 years was used in the analyses, which allowed us to investigate trends in infant 
mortality rates. Furthermore, our data were obtained from civil registers, which could 
have been influenced by a certain simplification of categorisation. Additionally, minor 
changes occurred in the structure of the reported data during the 50-year interval of the 
study. Over-dispersion did not influence our results as the negative binomial regression 
method was applied in both risk estimation and the investigation of annual mortality 
trend. 
In the seasonality, monthly cyclic trend analyses we used the Walter-Elwood method, 
which confirmed the findings of the logistic regression model since both gave similar 
results. Moreover, the longest study period was used in the seasonality analyses. The 
main shortcoming of this study is that we did not have information about the cause of 
infant death using the monthly frequencies to confirm the speculation of the infectious 
aetiology, although, a significant seasonal peak in February was found and the vast 
proportion (75%) of deaths occurred in the neonatal period. The month of infant deaths 
were based on date at death. Therefore in the seasonal analyses the months of births and 
months of death are only the same in the group of babies who died within 24 hours after 
birth. There was a small shift between the months of births and months of death in the 
group of the early neonatal deaths. However, this shift was undetectable in the group of 
all infant deaths. Therefore, the double peaks analyses revealed no significant 
seasonality in the group of all infant deaths. Thus, the effect of infections around birth 
was described by double peaks models. Moreover, the application of Bonferroni 
correction reduced the probability of chance findings in our analyses.  
 
5.1.2. Main findings 
The annual infant mortality rate declined 10-fold from its maximum value in 1963 to the 
minimum value in 2012. Nevertheless, a significantly increased risk of infant mortality 
 
 
29 
 
was observed in the low birth weight group compared with the normal birth weight 
group and lower maternal education also increased the risk of infant mortality. 
 
A seasonal peak rate was found in February in the analyses that investigated the 
monthly cyclic trend of infant deaths and a peak mortality rate was revealed in March in 
the early neonatal mortality. Although, we did not have data on the age or birth weight 
of infant related to the monthly numbers of death, we might speculate that the 
significant peak of neonatal and infant mortality could be related to respiratory 
infections at the end of winter [28].  
 
5.1.3. Comparison with other studies 
Similar to other studies in Europe [44-48] the rates of both neonatal and infant death 
significantly decreased in Hungary during the 50-year study period. However, these 
other studies investigated shorter periods than our study. Nevertheless, the Hungarian 
infant mortality rate of 4.9 per 1,000 live births in 2011, was higher than the reported 
Western European infant mortality rate, which was 3.2 per 1,000 live births in 2011 [4].  
 
Lin et al [49] investigated sex-specific risks and causes of mortality among low birth 
weight infants under one-year-of-age and found an RR of 8.99 in boys and an RR of 
8.29 in girls. However, in our study a much higher RR of 20.2 for infant mortality was 
observed in the low birth weight group. Furthermore, a significantly increased RR of 
1.23 for infant mortality was found in boys compared with girls.  
 
Some studies described differences in infant mortality among geographic areas within a 
country [14] and Corchia and Orzalesi [50] reported a lower socio-sanitary level in the 
South compared to the North of Italy. We did not have data on socio-demographic 
characteristics, but we have found a strong negative correlation between the real income 
per person of the overall population and the rate of stillbirth in a previous study [51]. 
However, we investigated the relationship between maternal education and infant 
mortality and found that the lower education of mothers also increased the risk of infant 
deaths compared to the higher educated groups. This is the same as the study by Ko et al 
[52], who reported that maternal education levels were also inversely related to infant 
mortality. Arntzen et al [53] also reported a persistent inverse association between 
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maternal educational level and neonatal death in a population-based study in the Nordic 
countries, but the published RRs were slightly lower than those were found in the 
present study. Similarly, Devlieger et al [54] found that increased infant mortality was 
associated with low levels of maternal education.  
 
Finally, a peak in mortality rates was found in February in an analysis that investigated 
the monthly cyclic trend of infant deaths using both logistic regression and the Walter-
Elwood methods. The later method was also applied in a study of analysis of seasonal 
variation of birth defects in Atlanta [55]. Seasonality of infant deaths was analysed by 
Hare et al [56] in relation to temperature changes. They reported that seasonal variations 
in the neonatal death rate were closely related to winter temperatures during the period 
1921-1960. Similarly, our findings suggest that the significant peak of neonatal and 
infant mortality could have been related to respiratory infections at the end of winter. 
Furthermore, in a recent study, we have detected significantly increased risk of 
childhood acute lymphoid leukaemia among children under one year of age residing in 
areas around birth with higher levels of mortality from influenza [57]. However, further 
cohort studies should be carried out to investigate this hypothesis, using detailed 
individual data including age at death, month of death, sex and birth weight.  
 
 
5.2. Chlamydia trachomatis infection and the risk of perinatal mortality in 
Hungary (Study II) 
 
5.2.1. Main findings 
A multicenter survey was carried out in order to determine the prevalence and risk 
factors of C. trachomatis infection in the population of asymptomatic women in 
Hungary. The overall average prevalence of C. trachomatis cases among 1,300 pregnant 
women was 4.5%, with an increase to 5.1% on the basis of the Bayesian approach. 
There were significant differences in the proportions of chlamydial infection in the 
different regions, and also in the different age groups and the different family status 
groups. The group aged under 20 years displayed 12.6% rate of infection. 
Using this rate in the cost-effective analysis, the most cost-effective strategy was 
strategy A: screening for C. trachomatis by using the ELISA method, however, strategy 
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B is the recommended method of screening since this strategy can prevent an additional 
10,000 more cases relative to strategy A. 
 
5.2.2. Strength and weaknesses 
This study was carried out to determine the prevalence and risk factors of C. 
Trachomatis in the population of asymptomatic women, however, the role of C. 
Trachomatis  in preterm birth was not investigated here. We adapted these findings 
from the parallel study which described the relationship between maternal chlamydial 
infection and preterm birth in Hungary [24,40-41]. However, our study was the first to 
investigate the cost-effectiveness of strategies to screen for C. trachomatis in Hungary. 
It is necessary to estimate the true prevalence of C. trachomatis infection because 
detection and treatment of asymptomatic cases have a major impact on the incidence of 
chlamydial infection, these asymptomatic individuals being an active source of new 
infections [58-60].
 
In epidemiology, certain methods have been suggested to correct for 
measurement error
 
[61]. In our analyses, a Bayesian approach was employed to correct 
measurement errors.  
Nevertheless, a cost-effectiveness study was carried out in 2008 [62]. The costs used in 
cost-effectiveness analysis were updated and reanalysed and similar findings were 
observed for the screening strategies of cervical infection with C. trachomatis as in the 
very first study.  
 
 
5.2.3. Comparison with other studies 
A precise estimation of the prevalence of C. trachomatis infection is important in cost-
effectiveness analysis. In developed countries, the debate on Chlamydia control has 
centered on the cost-effectiveness of different approaches for identifying infected 
persons
 
[63-68]. It has been concluded that, among women, case findings involving the 
use of laboratory tests is cost-effective at C. trachomatis prevalence rates as different as 
6% to 16%
 
. In the cost-effectiveness analysis, we accounted for asymptomatic PID and 
included direct costs only for outcomes that developed in women with untreated 
chlamydial infection. The most cost-effective strategy was strategy A (screening for C. 
trachomatis by using the ELISA method). Strategy B (screening for C. trachomatis by 
using the amplified Gen-Probe method) was slightly less cost-effective than neither 
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testing, nor treating (strategy C), but can prevent an additional 10,000 more cases 
relative to strategy A. When the estimated rate of infection of 16.9% in the age group 
under 20 years was taken into consideration, the established rate proved higher than that 
calculated in sensitivity analysis, and strategy B is therefore the recommended method 
of screening. 
The advent of available, simple and inexpensive screening tests has increased the 
possibility of routine prenatal screening for C. trachomatis. We conclude that age-based 
screening with amplified Gen-Probe assays (combined with treatment of positive 
patients and partner notification) is the preferred screening strategy for women in 
Hungary. Since the majority of the C. trachomatis-infected cases were asymptomatic, 
we suggest to use amplified Gen-Probe assays for screening of all women with evidence 
of mucopurulent cervicitis and all women of age group between 15-19 years who have 
had sexual intercourse. We also recommend testing women between 20 to 24 years of 
age who have not consistently used barrier contraception or have had a new sex partner 
or more than one sex partner during the past six months and testing the pregnant 
population before delivery and before artificial abortion and after spontaneous abortion. 
Furthermore, extension of the screening procedure to test all pregnant women for 
transplacentally or perinatally transmitted diseases comprises an important part of 
obstetrical care [69-72] considering that the rate of genital chlamydial infection has 
been increasing in Hungary since 2006.  
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6. CONCLUSIONS 
 
6.1. Trends in infant mortality rates in Hungary between 1963 and 2012  
(Study I) 
 
In this study, a number of risk factors and trends were investigated in relation to infant 
mortality using well established statistical methods. We found seasonal effects related to 
infant and early neonatal mortality, with peaks in February and March, when the rate of 
respiratory infections is the highest in Hungary. These findings could prove useful in 
preventive strategies, but further cohort studies should be carried out to investigate this 
hypothesis using detailed individual data. 
 
6.2. Chlamydia trachomatis infection and the risk of perinatal mortality in 
Hungary (Study II) 
 
The advent of available, simple and inexpensive screening tests has increased the 
feasibility of routine prenatal screening for C. trachomatis. We conclude that age-based 
screening with amplified Gen-Probe assays (combined with treatment of positive 
patients and partner notification) is the preferred screening strategy for women in 
Hungary. Furthermore, extension of the screening procedure to test all pregnant women 
for diseases that can be transmitted transplacentally or perinatally comprises an 
important part of obstetrical care.  
The introduction of the screening of C. trachomatis can reduce the sequelae of untreated 
C. trachomatis infections and can detect other STDs. This prevention may reduce the 
number of expensive diagnostic and therapeutic methods 
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7. SUMMARY 
7.1. Trends in infant mortality rates in Hungary between 1963 and 2012  
(Study I) 
 
Aim: A longitudinal study was used to investigate annual and seasonal death trends for 
infants of less than one-year-of-age in Hungary between 1963 and 2012 and analysed 
commonly accepted risk factors. 
Methods: Data on the numbers of live births and infant deaths were obtained from the 
published nationwide population register. Negative binomial regression was applied to 
investigate the yearly trends in rates and also the effect of possible risk factors - low 
birth weight, maternal education and sex - on infant mortality. Cyclic trends were 
investigated using logistic regression. 
Results: Annual infant mortality declined significantly (p<0.001) from 42.9 to 4.9 per 
1,000 live births per year during the study period and significantly increased (p<0.001) 
in the low birth weight group and lower maternal education groups. A significant 
(p<0.001) cyclic trend in mortality was revealed, with a peak in deaths in late February 
for all infants and a double peak, in May and November, in the group of cases who died 
during the early neonatal period.  
Conclusion: This Hungarian study suggests that there was a significant seasonal effect 
on neonatal and infant mortality at the end of winter between 1963 and 2012. We 
speculate that this may have been related to respiratory infections. 
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7.2. Chlamydia trachomatis infection and the risk of perinatal mortality in 
Hungary (Study II) 
 
Aim: A multicenter survey was carried out in 1995 in order to determine the prevalence 
and risk factors of Chlamydia trachomatis infection in the population of asymptomatic 
women in Hungary and to carry out a cost-effectiveness analysis to screen for 
chlamydial infection in women with asymptomatic genital infections.  
Methods: The non-amplified nucleic acid hybridization method (PACE 2 Gen-Probe) 
was applied for the examination of C. trachomatis. Today, the sensitivity and specificity 
of this method are only 70% and 99%, respectively, and Bayes’ theorem was therefore 
applied to assess the prevalence of the infection. Multiple logistic regression analysis 
was performed to differentiate the risk factors of chlamydial infections. 
Results: The overall average prevalence of Chlamydia trachomatis cases among 1300 
pregnant women was 4.5%. However, with Bayes' theorem the overall estimated 
prevalence of chlamydial infection was 5.1%. There were significant differences in the 
proportions of chlamydial infection in the different regions, and also in the different age 
groups and the different family status groups.  
Using results of the epidemiological study a cost-effectiveness analysis was carried out. 
When the estimated rate of infection of 16.9% in the age group under 20 years was 
taken into consideration, the established rate proved higher than that calculated in 
sensitivity analysis, and strategy screening for chlamydial infection by using the 
amplified Gen-Probe method is therefore the recommended method of screening. 
Discussion: We conclude that age-based screening with amplified Gen-Probe assays 
(followed by treatment of positive patients and partner notification) is the preferred 
screening strategy for women in Hungary. 
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KEY NOTES: 
 
 
 This study investigated annual and seasonal death trends for infants of less than 
one-year-of-age in Hungary from 1963-2012.  
 
 The highest risk of infant mortality with an RR of 20.2 (95% CI 19.9–20.4 
p<0.001) was observed in the low birth weight group compared with the normal 
birth weight group. 
 
 Annual infant mortality declined significantly during the study period and 
significantly increased in the low birth weight and lower maternal education 
groups.  
 
 A significant cyclic trend in mortality was revealed, with a peak in deaths in late 
winter for all infants and peaks in May and November for early neonatal infants. 
 
 Young age, unmarried status (single or divorced) and region proved to be 
statistically significant predictors of the genital chlamydial infection. 
 
 Age-based screening with amplified Gen-Probe assays (combined with treatment 
of positive patients and partners) is the preferred screening strategy of 
Chlamydia trachomatis for women in Hungary. 
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